Navigation Links
Medivation Announces Publication in The Lancet of Dimebon Pivotal Trial Results in Alzheimer's Disease
Date:7/17/2008

preclinical models relevant to Alzheimer's and Huntington's diseases, making it a potential treatment for these and other neurodegenerative diseases. Preclinical data generated to date suggest that Dimebon operates through a novel mitochondrial mechanism of action.

On July 7, 2008, Medivation announced positive safety and efficacy results from its Phase 2 trial of Dimebon for the treatment of Huntington's disease, which was conducted in collaboration with the Huntington Study Group. The study met its primary endpoint of safety and tolerability; in addition, Dimebon showed statistically significant benefit versus placebo in cognition as measured by the Mini-Mental State Examination, a secondary endpoint in the study. Huntington's disease is a progressive neurodegenerative disease characterized by the gradual development of involuntary muscle movement, progressive deterioration of cognitive processes and memory and severe behavioral disturbances. There are currently no approved drugs in the United States to treat this uniformly fatal genetic disorder.

About Alzheimer's Disease

Alzheimer's disease is a progressive, neurodegenerative disease that destroys brain cells and affects areas of the brain involved in memory, cognition, judgment, language and behavior, eventually leading to severe impairments in cognition and function. The most common form of dementia, Alzheimer's disease affects as many as 5 million Americans.

About Medivation

Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel small molecule drugs to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their caregivers. The Company's current clinical development program includes a pivotal and confirmatory Phase 3 trial of Dimebon in Alzheimer's disease and a Phase 1-2 clinical trial of MDV3100 in patients with castr
'/>"/>

SOURCE Medivation, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntingtons Disease
2. Medivation to Host Conference Call at 5 p.m. EDT Monday to Discuss Top-Line Phase 2 Study Results in Huntingtons Disease
3. Medivation Initiates Second Pivotal Phase 3 Trial of Dimebon(TM) in Patients With Alzheimers Disease
4. Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration-Resistant Prostate Cancer Patients at 44th ASCO Annual Meeting
5. Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting
6. Medivations Dimebon(TM) Significantly Improved Thinking and Memory in Alzheimers Disease Patients Over One Year
7. Medivations Dimebon(TM) Significantly Improved Daily Function in Alzheimers Disease Patients, Resulting in Reduced Need for Caregiver Assistance
8. Medivations Dimebon(TM) Stabilizes Behavioral Symptoms in Alzheimers Disease Patients, Resulting in Reduced Caregiver Distress
9. Medivations MDV3100 Demonstrates Substantial PSA Reductions in First Patient Groups Treated in Phase 1-2 Hormone Refractory Prostate Cancer Trial
10. Vical Announces Breakthrough for Pandemic Influenza DNA Vaccines With Preliminary Human Data
11. Biodel Inc. Announces the Completion of Its Two Pivotal Trials and the Release of EASD Abstracts Containing Additional Interim Data From Its VIAject(TM) Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... DUBLIN , Apr. 17, 2015 Research and ... addition of the "Medical Oxygen Systems - Global ... This report analyzes the worldwide markets for Medical ... Oxygen Concentrators, Liquid Oxygen Systems, Oxygen Cylinders & Regulators, ... analytics for the US, Canada , ...
(Date:4/17/2015)... 2015 Today, the Pharmaceutical Research and ... 12 biopharmaceutical companies as "We Work For Health ... and community service. Established in 2009, ... created by the biopharmaceutical industry to honor employees ... but have also shown an outstanding commitment to ...
(Date:4/17/2015)... Apr. 16, 2015 Research and Markets ... of the "The Corporate Reputation of Pharma ... Edition " report to their offering. ... Perspective, is now in its fourth edition. This ... early 2015). For each annual Corporate Reputation report, ...
Breaking Medicine Technology:Medical Oxygen Systems - 2015 Global Strategic Business Report Featuring Leading Players, Caire, Invacare & Philips Respironics 2PhRMA Applauds 2015 We Work For Health Champion Award Winners 2PhRMA Applauds 2015 We Work For Health Champion Award Winners 3The Corporate Reputation of Pharma - The Global Patient Perspective in 2014 2
... April 18, 2012 SurgLine International, Inc. (SGLN.PK) ... ("SurgLine") reported that the company has successfully completed its ... owned surgery center in the state of Indiana. The ... substantial savings over the competition. Toland ...
... Scripps Research Institute have shown that an injectable solution can ... findings could lead to human clinical trials of a treatment ... emergency. Cocaine is involved in more than 400,000 emergency-room visits ... States. The findings, reported recently in the journal ...
Cached Medicine Technology:SurgLine International, Inc. Update On New Revenues 2Scripps Research Institute Scientists Develop Antidote for Cocaine Overdose 2Scripps Research Institute Scientists Develop Antidote for Cocaine Overdose 3Scripps Research Institute Scientists Develop Antidote for Cocaine Overdose 4
(Date:4/19/2015)... 2015 Autocarinsurancecheap.com has released a new ... offer financial protection for vulnerable family members. , ... insured dies or is disabled in an accident. The ... bought with an auto insurance plan. However, AD&D insurance ... to a life insurance policy. The newly blog post ...
(Date:4/19/2015)... (PRWEB) April 19, 2015 Carinsurancehints.com has released ... who have to claim auto insurance benefits . ... pictures and gather all the necessary information for claiming auto ... a good insurance plan to cover most of the damages. ... insurance benefits for an accident. , Drivers can compare ...
(Date:4/19/2015)... April 19, 2015 Insurancecarsinsurance.com has released ... months and explaining how bad weather can affect ... have a big impact on auto insurance premiums. In ... auto insurance prices are higher than in other parts. ... will be during the next several months and what ...
(Date:4/19/2015)... A live auction will be held to ... hospital in Brooklyn, NY and other national consignors. Various types ... anesthesia, exam and much more. , The auction will ... at 9:00am CDT each day. The equipment is at their ... IL 60160. Anyone can participate in the auction including ...
(Date:4/19/2015)... MA (PRWEB) April 19, 2015 Family and ... Bowling for Brains in Memory of Brad Baddeley event ... Brain Aneurysm Foundation. , Bowling for Brains is cheduled to ... located 4700 Dudley Street in Lincoln, Nebraska. Participants may arrive ... 1:00 to 3:00pm. , The cost is only $4 per ...
Breaking Medicine News(10 mins):Health News:Accidental Death and Dismemberment Insurance Can Provide Financial Security! 2Health News:An Online Guide About Claiming Auto Insurance Benefits After an Accident 2Health News:Bad Weather Can Cause Accidents and Affect Auto Insurance Prices! 2Health News:Centurion to Sell Surplus Medical Equipment in Online and On-Site Auction 2Health News:Lincoln, NE’s Bowling for Brains to benefit Renowned Brain Aneurysm Foundation 2Health News:Lincoln, NE’s Bowling for Brains to benefit Renowned Brain Aneurysm Foundation 3
... Network, the prominent advocacy group launches the inaugural World ... site, www.worldmrsaday.org . MRSA activists ... and the community for a greater response to the ... alarming rate.MRSA Survivors Network, the official organization for World ...
... 5 The World Health Organization says a Swine ... already declared emergencies. Many experts believe the Federal government ... the outbreak takes on the public will become increasing ... of panic. Your only defense: to prepare your department ...
... Give Voice to Improving Quality Care and Quality Careers , ... for better senior living, celebrates National Nurse Week May 6-12, ... how to improve the business, the quality of care and ... Vigilan is offering an online and phone-based survey where ...
... Indiana University School of Medicine , the not-for-profit Taking Control ... for people living with diabetes on May 30 from 9 ... The TCOYD conference, lunch and health fair brings national and ... types of diabetes, those at risk for diabetes, and their ...
... Society of Cellular Therapy (ISCT) Demonstrating Potential to ... in TransplantationOLDSMAR, Fla., May 5 /PRNewswire-FirstCall/ -- ... new study showing that adding menstrual blood stem ... blood expands the number of progenitor cells (cells ...
... Inc. (Nasdaq: CYNO ), a ... light-based aesthetic treatment systems, today announced financial results for ... 2009 Financial Results , Consistent with Cynosure,s ... March 31, 2009 were $14.8 million, reflecting the continued ...
Cached Medicine News:Health News:MRSA Activists Rally For World MRSA Day 2Health News:Ready or Not - Flu Pandemic Has Arrived 2Health News:Vigilan Honors National Nurse Week in Assisted Living, Independent Living and Dementia Care 2Health News:Taking Control of Your Diabetes Conference Returns to Indianapolis to Bring Answers, Advocacy and Hope for People With Diabetes 2Health News:Taking Control of Your Diabetes Conference Returns to Indianapolis to Bring Answers, Advocacy and Hope for People With Diabetes 3Health News:Menstrual Blood Stem Cells May Significantly Increase Yield of Cord Blood Stem Cells 2Health News:Menstrual Blood Stem Cells May Significantly Increase Yield of Cord Blood Stem Cells 3Health News:Menstrual Blood Stem Cells May Significantly Increase Yield of Cord Blood Stem Cells 4Health News:Menstrual Blood Stem Cells May Significantly Increase Yield of Cord Blood Stem Cells 5Health News:Cynosure Reports Financial Results for the First Quarter of 2009 2Health News:Cynosure Reports Financial Results for the First Quarter of 2009 3Health News:Cynosure Reports Financial Results for the First Quarter of 2009 4Health News:Cynosure Reports Financial Results for the First Quarter of 2009 5Health News:Cynosure Reports Financial Results for the First Quarter of 2009 6Health News:Cynosure Reports Financial Results for the First Quarter of 2009 7Health News:Cynosure Reports Financial Results for the First Quarter of 2009 8Health News:Cynosure Reports Financial Results for the First Quarter of 2009 9Health News:Cynosure Reports Financial Results for the First Quarter of 2009 10
2.5 mm x 4 mm opening. Hexagonal handle....
Double-ended. Designated most popular model or size....
Double-ended. Sharp and blunt 6.5 mm tips. Designated most popular model or size....
2 mm tip....
Medicine Products: